Materials Healthcare Sector

LianBio

Market Cap: US$41.1m

A biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries.

Pluri

Market Cap: US$40.6m

A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries.

CRUSHMETRIC Group

Market Cap: UK£30.5m

A design and production company, integrates shape changing technology into catalogue of products in Hong Kong, Mainland China, and Singapore.

Cryo-Cell International

Market Cap: US$40.5m

Engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.

Firefly Neuroscience

Market Cap: US$40.4m

A medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders.

Oncolytics Biotech

Market Cap: CA$56.3m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Bioqual

Market Cap: US$40.2m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Atara Biotherapeutics

Market Cap: US$40.1m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

electroCore

Market Cap: US$40.1m

A bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.

Global Innovative Platforms

Market Cap: US$39.8m

Engages in the business of testing breath to detect and assist in the treatment of disease.

New Green Hemp

Market Cap: US$39.8m

New Green Hemp Inc. cultivates and sells hemp products.

Sharp Therapeutics

Market Cap: CA$55.4m

A biology technology company, develops medicines specific for genetic diseases.

Modular Medical

Market Cap: US$39.4m

Operates as a medical device company.

Positron

Market Cap: US$39.1m

A nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States.

Comjoyful International

Market Cap: US$39.1m

Operates and manages healthcare clubs in China.

Grace Therapeutics

Market Cap: US$38.4m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Reviva Pharmaceuticals Holdings

Market Cap: US$38.3m

A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

Pacific Edge

Market Cap: NZ$65.0m

A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.

Barinthus Biotherapeutics

Market Cap: US$38.1m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

Daxor

Market Cap: US$37.8m

A medical device company, provides blood volume measurement technology focused on blood volume testing.

Quince Therapeutics

Market Cap: US$37.4m

A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.

Futura Medical

Market Cap: UK£28.1m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Boundless Bio

Market Cap: US$36.9m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

NurExone Biologic

Market Cap: CA$51.5m

Operates as a pharmaceutical technology company.

Rani Therapeutics Holdings

Market Cap: US$36.8m

Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.

Simply Solventless Concentrates

Market Cap: CA$51.4m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Akari Therapeutics

Market Cap: US$36.7m

An oncology company, develops next-generation antibody-drug conjugates (ADC) and a novel discovery engine.

Concord Medical Services Holdings

Market Cap: US$36.5m

Through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.

AN2 Therapeutics

Market Cap: US$36.4m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Helix BioPharma

Market Cap: CA$50.9m

Operates as an immune-oncology company in Canada.

Spero Therapeutics

Market Cap: US$36.4m

A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.

Compumedics

Market Cap: AU$56.7m

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe.

Renalytix

Market Cap: UK£27.3m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.

Acrivon Therapeutics

Market Cap: US$36.1m

A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

Defence Therapeutics

Market Cap: CA$50.3m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

Envoy Medical

Market Cap: US$35.8m

A hearing health company, focuses on providing medical technologies across the hearing loss spectrum.